Ciclesonide Pregnancy and Breastfeeding Warnings
Brand names: Alvesco
Medically reviewed by Drugs.com. Last updated on Jun 19, 2023.
Ciclesonide Pregnancy Warnings
Use is not recommended unless the benefit outweighs the risk to the fetus
AU TGA pregnancy category: B3
US FDA pregnancy category: C
Comments:
-Asthma should be closely monitored and medication adjusted as necessary to maintain optimal asthma control in pregnant women.
-Infants exposed to corticosteroids in utero should be observed for signs and symptoms of hypoadrenalism.
Ciclesonide Breastfeeding Warnings
Benefit should outweigh risk
Excreted into human milk: Unknown
Excreted into animal milk: Yes
Comment: Inhaled corticosteroids are generally considered acceptable to use during breastfeeding as the amount, if excreted into breastmilk, would probably be too small to affect a breastfed infant.
See also
References for pregnancy information
- Cerner Multum, Inc. UK Summary of Product Characteristics.
- Product Information. Alvesco (ciclesonide). Nycomed USA. 2008.
- Cerner Multum, Inc. Australian Product Information.
References for breastfeeding information
- Cerner Multum, Inc. UK Summary of Product Characteristics.
- Product Information. Alvesco (ciclesonide). Nycomed USA. 2008.
- Cerner Multum, Inc. Australian Product Information.
- United States National Library of Medicine. Toxnet. Toxicology Data Network. http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?LACT 2013.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
